10 Years Of MedImmune: How Patent Owners Fared
Last month marked 10 years since the U.S. Supreme Court sided with MedImmune in a royalty dispute with Genentech, transferring the power within a license agreement from the licensor to the...To view the full article, register now.
Already a subscriber? Click here to view full article